Blade Therapeutics Garners $45,000,000 Series B Funding

  • Feed Type
  • Date
    6/20/2016
  • Company Name
    Blade Therapeutics
  • Mailing Address
    442 Littlefield Avenue South San Francisco, CA 94080 USA
  • Company Description
    Blade Therapeutics is a private biopharmaceutical company revolutionizing the treatment of fibrotic disease. Blade’s novel target biology was discovered by its founder, Hal Dietz, M.D., Victor A. McKusick Professor of Genetics and Medicine, Johns Hopkins University.
  • Website
    http://www.blademed.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to advance the selection and development of lead molecules designed to modify the pathobiology of fibrotic diseases.
  • M&A Terms
  • Venture Investor
    Deerfield Capital
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Novartis BioVenture Fund
  • Venture Investor
    MPM Capital
  • Venture Investor
    Osage Partners

Trending on Xconomy